Breaking US Military Halts Airstrikes on Iran Amid Diplomatic Push U.S. Senate Races Dynamic as Key Primaries Conclude Myles Garrett Makes Immediate Impact in First Los Angeles Rams Practice Ser Criston Cole Meets His End in “House of the Dragon” Episode 6 Multiple Injured in Sunday Night Shooting Near Seattle’s Space Needle

Monday July 27, 2026

Reporter

Alpha Tau Medical Ltd.

1Articles Published

4Communities Covered

Published Articles

Press Release

Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study’s Pre-Specified Threshold for Success

Jul 21